Drug intelligence / Profile preview

Peristem

Development stage
Unknown
Lead developer
Tissue Regeneration Therapeutics
Modality
Stem Cell Therapies → Cell Therapies
Administration
Intravenous, Local Injection
01

Overview

Peristem is a proprietary cell therapy product composed of human umbilical cord perivascular cells (HUCPVCs), a specific population of mesenchymal stromal cells (MSCs) harvested from the connective tissue surrounding the blood vessels of the umbilical cord. Developed by Tissue Regenerative Therapeutics (TRT), Peristem cells are characterized by a significantly higher frequency of MSC progenitors and greater proliferative potential compared to cells derived from Wharton's jelly or cord blood. The therapeutic mechanism of Peristem is primarily mediated through paracrine signaling, where the cells secrete a diverse secretome of growth factors, cytokines, and extracellular vesicles that promote angiogenesis, facilitate tissue regeneration, and exert potent immunomodulatory effects. Peristem is being developed for a range of indications in regenerative medicine, including the treatment of critical limb ischemia, bone repair, wound healing, and various inflammatory and autoimmune disorders.

Brand names
PeriStem
Other names
Human Umbilical Cord Perivascular CellsUmbilical Cord Perivascular Cells

Beyond the preview

Go deeper on Peristem.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Peristem.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call